Evidence map›Paper›PMID 35156411›Full record

ArticleCell transplantation

Intracameral Microimaging of Maturation of Human iPSC Derivatives into Islet Endocrine Cells.

Kaixuan Zhao, Yue Shi, Jia Yu, Lina Yu, Amber Mael, Yuxin Li, Anthony Kolton, Thomas Joyce, Jon Odorico, Per-Olof Berggren and 1 more

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. In Vivo CaBiomedicines · 2023
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Kaixuan ZhaoThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Yue ShiThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Jia YuThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Lina YuThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Amber MaelRegenerative Medical Solutions, Inc., Madison, WI, USA.
Yuxin LiNational Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, China.
Anthony KoltonRegenerative Medical Solutions, Inc., Madison, WI, USA.
Thomas JoyceRegenerative Medical Solutions, Inc., Madison, WI, USA.
Jon OdoricoRegenerative Medical Solutions, Inc., Madison, WI, USA.
Per-Olof BerggrenThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.
Shao-Nian YangThe Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden.ORCID 0000-0001-7470-7197
Karolinska University Hospital · SERegenerative Medical Solutions (United States) · USNortheast Normal University · CN

Funding

Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testingR44DK104497 · NIDDK · REGENERATIVE MEDICAL SOLUTIONS, INC. · PI FORSBERG, ERIK J · 2015 to 2016
$1.5M
Development of a rapid and inexpensive luciferase-based high throughput screening assay to identify compounds that alter pancreatic β cell functionR43DK112472 · NIDDK · REGENERATIVE MEDICAL SOLUTIONS, INC. · PI FORSBERG, ERIK J · 2016 to 2016
$225k
Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cellsR43DK108441 · NIDDK · REGENERATIVE MEDICAL SOLUTIONS, INC. · PI FORSBERG, ERIK J · 2016 to 2016
$225k
Human Induced Pluripotent Stem Cell-Derived Beta-Cells for Drug and Toxicity TestingR43DK104497 · NIDDK · REGENERATIVE MEDICAL SOLUTIONS, INC. · PI FORSBERG, ERIK J · 2014 to 2014
$222k
Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applicationsR43DK109832 · NIDDK · REGENERATIVE MEDICAL SOLUTIONS, INC. · PI FORSBERG, ERIK J · 2016 to 2016
$217k
NIDDK NIH HHS R43 DK104497NIDDK NIH HHS R43 DK108441NIDDK NIH HHS R43 DK109832NIDDK NIH HHS R43 DK112472NIDDK NIH HHS R44 DK104497
6 · The paper itself

Abstract

We exploited the anterior chamber of the eye (ACE) of immunodeficient mice as an ectopic site for both transplantation and microimaging of engineered surrogate islets from human induced pluripotent stem cells (hiPSC-SIs). These islets contained a majority of insulin-expressing cells, positive or negative for PDX1 and NKX6.1, and a minority of glucagon- or somatostatin-positive cells. Single, non-aggregated hiPSC-SIs were satisfactorily engrafted onto the iris. They underwent gradual vascularization and progressively increased their light scattering signals, reflecting the abundance of zinc-insulin crystal packaged inside mature insulin secretory granules. Intracameral hiPSC-SIs retrieved from recipients showed enhanced insulin immunofluorescence in correlation with the parallel increase in overall vascularization and light backscattering during the post-transplantation period. This approach enables longitudinal, nondestructive and intravital microimaging of cell fates, engraftment, vascularization and mature insulin secretory granules of single hiPSC-SI grafts, and may offer a feasible and reliable means to screen compounds for promoting in vivo hiPSC-SI maturation.

Indexed as

Induced Pluripotent Stem CellsInsulin-Secreting CellsIslets of LangerhansIslets of Langerhans TransplantationAnimalsHumansInsulinMiceInsulinbackscatteringhuman induced pluripotent stem cells (hiPSCs)in vivo confocal microscopysurrogate isletthe anterior chamber of the eye (ACE)transplantationvascularization

Identifiers

PMID35156411
PMCPMC8848082
OpenAlexW4212978767

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.